Summary
Immunopotentiators such as BCG, levamisole, PS-K and OK-432 prevent carbon tetrachloride (CCl4) hepatotoxicity, and in spite of exposure to CCl4 the liver tissue levels of thiobarbituric acid (TBA) reactive substances were not increased in rats pretreated with such immunopotentiators.
Similar content being viewed by others
Literature
R. O. Recknagel, Pharmac. Rev.19, 145 (1967).
J. Akiyama, T. Kawamura, E. Gotohda, Y. Yamada, M. Hosokawa, T. Kodama and H. Kobayashi, Cancer Res.37, 3042 (1977).
N. Sakai, K. Ryoyama, S. Koshimura and S. Migita, Jap. J. exp. Med.46, 123 (1976).
K. S. Kumar, M. A. Chirigos and J. F. Weiss, Int. J. Immunopharac.1, 85 (1979).
H. Ohkawa, N. Ohishi and K. Yagi, Analyt. Biochem.95, 351 (1979).
S. Reitman and S. Frankel, Am. J. clin. Path.28, 56 (1957).
A. L. Tappel, Fedn Proc.32, 1870 (1973).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yoshikawa, T., Furukawa, Y., Wakamatsu, Y. et al. Immunopetentiators and the protection they give against carbon tetrachloride hepatotoxicity. Experientia 38, 501–502 (1982). https://doi.org/10.1007/BF01952661
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01952661